Literature DB >> 16477606

Clinical curiosity: cribriform-morular variant of papillary thyroid carcinoma.

Kimberly M Dalal1, Dimitrios Moraitis, Carlos Iwamoto, Ashok R Shaha, Snehal G Patel, Ronald A Ghossein.   

Abstract

BACKGROUND: There is an increasing awareness of the association of papillary thyroid carcinoma and familial adenomatous polyposis (FAP). Although the incidence is rare, most tend to occur in women. Several authors have described a distinctive histologic variant of papillary thyroid carcinoma, the cribriform-morular variant, which is associated with FAP but also may be encountered in patients with non-FAP. This diagnosis may precede the symptoms of colorectal polyposis.
METHODS: A healthy 36-year-old woman was seen with a left thyroid nodule, and a 34-year-old woman with FAP was seen with a right thyroid nodule; both masses were suspicious for papillary thyroid carcinoma. Both patients underwent total thyroidectomy.
RESULTS: Pathologic examination of both specimens revealed papillary thyroid carcinoma, cribriform-morular variant. The first patient subsequently underwent colonoscopy, which was negative for polyposis.
CONCLUSIONS: Patients diagnosed with the cribriform-morular variant of papillary thyroid cancer should be screened for the presence of FAP. Copyright 2005 Wiley Periodicals, Inc.

Entities:  

Mesh:

Year:  2006        PMID: 16477606     DOI: 10.1002/hed.20383

Source DB:  PubMed          Journal:  Head Neck        ISSN: 1043-3074            Impact factor:   3.147


  3 in total

1.  Thyroid Carcinomas That Occur in Familial Adenomatous Polyposis Patients Recurrently Harbor Somatic Variants in APC, BRAF, and KTM2D.

Authors:  Taina T Nieminen; Christopher J Walker; Alisa Olkinuora; Luke K Genutis; Margaret O'Malley; Paul E Wakely; Lisa LaGuardia; Laura Koskenvuo; Johanna Arola; Anna H Lepistö; Pamela Brock; Ayse Selen Yilmaz; Ann-Kathrin Eisfeld; James M Church; Päivi Peltomäki; Albert de la Chapelle
Journal:  Thyroid       Date:  2020-03       Impact factor: 6.568

2.  Prognostic factors of papillary and follicular carcinomas in Japan based on data of kuma hospital.

Authors:  Yasuhiro Ito; Akira Miyauchi
Journal:  J Thyroid Res       Date:  2011-09-29

3.  Targeted Mutational Profiling and a Powerful Risk Score as Additional Tools for the Diagnosis of Papillary Thyroid Cancer.

Authors:  Barbara Kocsis-Deák; Kristóf Árvai; Bernadett Balla; Bálint Tóbiás; Andrea Kohánka; Balázs Járay; János Horányi; János Podani; István Takács; Zsuzsanna Putz; János Kósa; Péter Lakatos
Journal:  Pathol Oncol Res       Date:  2019-11-22       Impact factor: 3.201

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.